Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Neogen (NEOG)

Neogen Names Avi Pelossof to Board; Director William Boehm to Retire October 23

Neutral Impact 2 of 5 leadership Written later

Neogen appointed Avi Pelossof as a director effective October 24, 2025, and director William Boehm will retire from the board when his term ends on October 23, 2025. Boehm has served on the board since 2011 and chairs the Audit Committee, so the filing signals a change in that committee's leadership, though the filing does not name a successor chair.

Key points

  • Avi Pelossof appointed to the board effective October 24, 2025 as a Class II director
  • William T. Boehm, a director since 2011, retires when his term ends October 23, 2025
  • Boehm chairs the Audit Committee and serves on the Compensation & Talent Management Committee
  • Pelossof previously served as CEO and President of Immucor Inc. and held a senior role at Alere Inc.

The filing

CompanyNeogen (NEOG)
Form8-K, current report
Filed with the SECAug 14, 2025, 4:18 PM ET
Accession number0000950170-25-108900

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 14, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.